<!DOCTYPE html>
<html lang="en" data-theme="light">
<head>
    <meta charset="UTF-8">
    <meta name="viewport" content="width=device-width, initial-scale=1.0">
    <title>Antigen-Antibody Reaction in Vitro - Medical Microbiology</title>
    
    <link rel="preconnect" href="https://fonts.googleapis.com">
    <link rel="preconnect" href="https://fonts.gstatic.com" crossorigin>
    <link href="https://fonts.googleapis.com/css2?family=Inter:wght@400;500;600;700&family=Source+Serif+4:opsz,wght@8..60,400;8..60,600&display=swap" rel="stylesheet">
    
    <!-- KaTeX for Math rendering -->
    <link rel="stylesheet" href="https://cdn.jsdelivr.net/npm/katex@0.16.9/dist/katex.min.css">
    <script defer src="https://cdn.jsdelivr.net/npm/katex@0.16.9/dist/katex.min.js"></script>
    <script defer src="https://cdn.jsdelivr.net/npm/katex@0.16.9/dist/contrib/auto-render.min.js" onload="renderMathInElement(document.body, {
        delimiters: [
            {left: '$$', right: '$$', display: true},
            {left: '$', right: '$', display: false}
        ]
    });"></script>
    
    <link rel="stylesheet" href="../styles/main.css">
</head>
<body>
    <a href="#main-content" class="skip-link">Skip to main content</a>
    
    <button class="theme-toggle" id="theme-toggle" aria-label="Toggle dark mode">
        <span class="theme-toggle-icon light-icon">‚òÄÔ∏è</span>
        <span class="theme-toggle-icon dark-icon">üåô</span>
    </button>

    <div class="reading-progress-container">
        <div class="reading-progress-bar" id="reading-progress"></div>
    </div>

    <div class="page-wrapper">
        <div class="container">
            <article class="document-article">
                
                <!-- TOP NAVIGATION -->
                <nav class="document-nav" role="navigation" aria-label="Document Navigation">
                    <div class="nav-links">
                        <a href="topic-03-specific-immune-response.html" class="nav-button nav-button--previous">
                            <span class="nav-icon">‚Üê</span>
                            <span class="nav-text">Previous</span>
                        </a>
                        
                        <a href="../index.html" class="nav-button">
                            <span class="nav-icon">üè†</span>
                            <span class="nav-text">Home</span>
                        </a>
                        
                        <a href="topic-05-serodiagnostic-tests.html" class="nav-button nav-button--next">
                            <span class="nav-text">Next</span>
                            <span class="nav-icon">‚Üí</span>
                        </a>
                    </div>
                    <div class="document-progress">
                        <div class="progress-bar" aria-hidden="true">
                            <div class="progress-fill" style="width: 80%;"></div>
                        </div>
                        <span class="progress-text">Topic 4 of 5</span>
                    </div>
                </nav>

                <header class="document-header">
                    <div class="header-badge">
                        <span>üß™</span>
                        <span>Topic 04</span>
                    </div>
                    <h1 class="document-title">Antigen-Antibody Reaction in Vitro</h1>
                    <div class="title-meta">
                        <div class="meta-item">
                            <span>üìö</span>
                            <span>Basic Immunology and Serodiagnosis</span>
                        </div>
                        <div class="meta-item">
                            <span>‚è±Ô∏è</span>
                            <span>25 min read</span>
                        </div>
                    </div>
                </header>

                <main id="main-content" class="content-wrapper">
                    
                    <p>Antigen and its homologous antibody react with each other specifically. The main purpose of this reaction, occurring in vivo, is to protect the body from the harmful effects of antigens such as pathogenic bacteria and viruses. Antibodies bring about this destruction of antigens by various biological activities such as opsonisation, lysis, neutralization of toxins and viruses etc. This is the basis of antibody mediated immunity (AMI). However, sometimes antibodies may lead to tissue damage as in hypersensitivity reactions and autoimmune diseases.</p>
                    <p>In the laboratory, the specificity of antigen-antibody reactions is employed either for the detection and/or identification of antigens, which may be in the form of infectious agents or their metabolic products; or for the detection of antibodies produced by the host in response to a stimulus by a specific antigen. Antigen-antibody reactions performed in vitro for the purpose of diagnosis are known as serological tests.</p>

                    <!-- Section 1: Measurement -->
                    <section class="content-section" id="measurement">
                        <div class="section-header">
                            <div class="section-number">01</div>
                            <h2 class="section-title">
                                <span class="title-icon">üìè</span>
                                Measurement of Antigen and Antibody
                            </h2>
                        </div>

                        <div class="content-card">
                            <p>The reactions between antigens and antibodies can occur at various levels. Initially, the specific antigen and antibody may bind with each other without any visible effects. Such reactions can be made visible using various types of markers such as enzymes, fluorescent dyes and radioactive isotopes.</p>
                            <p>In some cases, antigen-antibody reaction may be demonstrable in the form of precipitation, agglutination, lysis of cells, killing of live organisms, neutralisation of toxic activity or enhancement of phagocytic activity. The technique used for the detection of antigen-antibody reaction depends on the type and level of activity.</p>
                            
                            <p>Serological techniques can be divided into two main groups:</p>
                            <p><strong>Antigen tests</strong> These tests employ known, specific antibodies (antisera) to detect and identify antigens in the specimens or in the causative agent isolated from the specimens.</p>
                            <p><strong>Antibody tests</strong> In these tests, known antigens are used to detect and measure specific antibodies in patient's serum in response to a suspected infection. The amount of antibody in the serum or any other body fluid is expressed as its titre. The antibody titre of a serum is the highest dilution of the serum which reacts with known specific antigen in an observable manner.</p>
                            
                            <p>The technique for the measurement of an antibody in patient's serum, in its simplest form, involves:</p>
                            <ol class="enhanced-list">
                                <li class="list-item">
                                    <span class="list-marker"></span>
                                    <span class="list-content">(i) Preparation of serial dilutions of the serum e.g. 1:2, 1:4, 1:8, 1:16 ..., etc.</span>
                                </li>
                                <li class="list-item">
                                    <span class="list-marker"></span>
                                    <span class="list-content">(ii) Addition of a constant volume of the known antigen suspension to each dilution.</span>
                                </li>
                                <li class="list-item">
                                    <span class="list-marker"></span>
                                    <span class="list-content">(iii) Incubation of the antigen-antibody mixture under optimum conditions, for the reaction to occur.</span>
                                </li>
                                <li class="list-item">
                                    <span class="list-marker"></span>
                                    <span class="list-content">(iv) Detection of the reaction either directly or with the help of markers or indicator systems, in each dilution of the serum.</span>
                                </li>
                                <li class="list-item">
                                    <span class="list-marker"></span>
                                    <span class="list-content">(v) Interpretation of the antibody titre i.e. the highest dilution of the serum which shows evidence of antigen-antibody reaction. For example, the antibody titre is '16' if the highest dilution of the serum showing a positive reaction is 1:16 as shown in Figure 4.1.</span>
                                </li>
                            </ol>

                            <figure class="content-figure" data-lightbox="true">
                                <div class="figure-image-wrapper">
                                    <img src="../assets/images/image-20251219-b40c26ee.jpeg" alt="Titration of antibodies" class="figure-image">
                                    <div class="figure-overlay">
                                        <span class="overlay-icon">üîç</span>
                                        <span class="overlay-text">Click to enlarge</span>
                                    </div>
                                </div>
                                <figcaption class="figure-caption">Fig. 4.1 Titration of antibodies</figcaption>
                            </figure>
                        </div>
                    </section>

                    <!-- Section 2: Dilutions -->
                    <section class="content-section" id="dilutions">
                        <div class="section-header">
                            <div class="section-number">02</div>
                            <h2 class="section-title">
                                <span class="title-icon">‚öóÔ∏è</span>
                                Preparation of Simple and Serial Dilutions
                            </h2>
                        </div>

                        <div class="content-card">
                            <h3>Simple Dilution</h3>
                            <p>To prepare a simple dilution, a given volume of the substance to be diluted, e.g. serum, is added to a constant volume of a diluent e.g. saline. A given volume of a desired dilution of serum may be prepared using the formula:</p>
                            
                            <div class="equation">
                                $$\frac{\text{Volume of serum}}{\text{Total volume}} = \text{Dilution}$$
                            </div>
                            
                            <p>where dilution is expressed as a fraction (1/x). For example, to prepare 2 ml (Total volume) of 1:20 dilution, the volume of serum required is</p>
                            
                            <div class="equation">
                                $$\frac{\text{Volume of serum}}{2.0 \text{ ml}} = \frac{1}{20}$$
                            </div>
                            
                            <p>i.e. Volume of serum = $\frac{2}{20} = \frac{1}{10} \text{ ml} = 0.1 \text{ ml}$</p>
                            <p>i.e. 0.1 ml of serum, when diluted to a total volume of 2.0 ml, will give 1:20 dilution.</p>
                            <p>Therefore, volume of diluent (e.g. saline) needed = Total volume ‚Äì volume of patient‚Äôs serum = 2.0 ml ‚Äì 0.1 ml = 1.9 ml.</p>
                            <p>To prepare 2.0 ml of 1:20 dilution of serum, add 1.1 ml of serum to 1.9 ml of saline.</p>
                            
                            <p>The formula $\frac{RV}{O}$ can also be used for making dilutions</p>
                            <p>Where<br>
                            R = Required concentration (dilution)<br>
                            V = Total volume required<br>
                            O = Original concentration</p>

                            <h3>Serial Dilution</h3>
                            <p>Serial dilutions are dilutions in progressive, regular increments, resulting in a series of dilutions in which, each dilution is less concentrated than the preceding one by a constant amount.</p>
                            <p>For example, a two-fold or doubling dilution series consists of</p>
                            
                            <div class="table-wrapper">
                                <div class="table-container">
                                    <table class="content-table content-table--compact">
                                        <thead>
                                            <tr>
                                                <th>Tube No.</th>
                                                <th>1</th>
                                                <th>2</th>
                                                <th>3</th>
                                                <th>4</th>
                                                <th>5</th>
                                            </tr>
                                        </thead>
                                        <tbody>
                                            <tr>
                                                <td>Dilution</td>
                                                <td>1:2</td>
                                                <td>1:4</td>
                                                <td>1:8</td>
                                                <td>1:16</td>
                                                <td>1:32</td>
                                            </tr>
                                        </tbody>
                                    </table>
                                </div>
                            </div>
                            
                            <p>i.e. tube No.2 is 1:2 dilution of tube No.1; tube No.3 is 1:2 dilution of tube No.2 and so on.</p>
                            <p>Two-fold dilutions can be prepared as shown in the table below.</p>

                            <div class="table-wrapper">
                                <div class="table-header">
                                    <span class="table-icon">üß™</span>
                                    <span class="table-title">Protocol for Two-fold Serial Dilution</span>
                                </div>
                                <div class="table-container">
                                    <table class="content-table">
                                        <thead>
                                            <tr>
                                                <th>Tube No.</th>
                                                <th>1</th>
                                                <th>2</th>
                                                <th>3</th>
                                                <th>4</th>
                                                <th>5</th>
                                            </tr>
                                        </thead>
                                        <tbody>
                                            <tr>
                                                <td>Saline</td>
                                                <td>0.5 ml</td>
                                                <td>0.5 ml</td>
                                                <td>0.5 ml</td>
                                                <td>0.5 ml</td>
                                                <td>0.5 ml</td>
                                            </tr>
                                            <tr>
                                                <td>Serum</td>
                                                <td>0.5ml</td>
                                                <td>Mix 0.5ml</td>
                                                <td>Mix 0.5ml</td>
                                                <td>Mix 0.5ml</td>
                                                <td>Mix 0.5ml</td>
                                            </tr>
                                            <tr>
                                                <td>Dilutions</td>
                                                <td>1:2</td>
                                                <td>1:4</td>
                                                <td>1:8</td>
                                                <td>1:16</td>
                                                <td>1:32</td>
                                            </tr>
                                        </tbody>
                                    </table>
                                </div>
                            </div>

                            <p><strong>Variations</strong> The volume of a dilution may be changed to the desired volume e.g. 0.1ml, 1.0ml, 2.0 ml etc. while keeping the proportion constant. The dilutions may be carried out in the same way up to any desired dilution e.g. up to tube 10. Sometimes, instead of starting from the first dilution (e.g. 1:2), the test may be started from the third (1:8) or fourth (1:16) dilutions.</p>
                            <p>The dilutions of the serum can be prepared in tubes or in wells of a microtitre plate where much smaller volumes can be used.</p>
                        </div>
                    </section>

                    <!-- Section 3: Characteristics -->
                    <section class="content-section" id="characteristics">
                        <div class="section-header">
                            <div class="section-number">03</div>
                            <h2 class="section-title">
                                <span class="title-icon">üìã</span>
                                Characteristics of Antigen-Antibody Reactions
                            </h2>
                        </div>

                        <div class="content-card">
                            <p>Generally, antigens and antibodies observe the following rules when they react:</p>
                            <ol class="enhanced-list">
                                <li class="list-item">
                                    <span class="list-marker"></span>
                                    <span class="list-content">(i) The reaction is specific: The antigen reacts only with its specific antibody, and vice-versa. However, this specificity is not absolute and cross-reactions do occur between related antigens and antibodies.</span>
                                </li>
                                <li class="list-item">
                                    <span class="list-marker"></span>
                                    <span class="list-content">(ii) Reaction occurs at surface: The combining groups of antigen and antibody are present on the surface of these molecules. Therefore, surface antigens are immunologically most relevant.</span>
                                </li>
                                <li class="list-item">
                                    <span class="list-marker"></span>
                                    <span class="list-content">(iii) Entire molecules, and not the fragments, take part in the reaction, even when the antigen or antibody is absorbed on a carrier molecule.</span>
                                </li>
                                <li class="list-item">
                                    <span class="list-marker"></span>
                                    <span class="list-content">(iv) The combination of antigen-antibody is firm, but reversible. The firmness depends on two factors; affinity, or the intensity of attraction; and avidity, or the strength of the bond between them.</span>
                                </li>
                                <li class="list-item">
                                    <span class="list-marker"></span>
                                    <span class="list-content">(v) There is no chemical change or denaturations in either the antigen or the antibody molecule after the reaction.</span>
                                </li>
                                <li class="list-item">
                                    <span class="list-marker"></span>
                                    <span class="list-content">(vi) Unlike chemical reactions with reactants, antigens and antibodies can react in varying proportions. However, to result in a visual effect such as precipitation and agglutination, they must be in optimal proportions.</span>
                                </li>
                            </ol>
                        </div>
                    </section>

                    <!-- Section 4: Monoclonal Antibodies -->
                    <section class="content-section" id="monoclonal-antibodies">
                        <div class="section-header">
                            <div class="section-number">04</div>
                            <h2 class="section-title">
                                <span class="title-icon">üî¨</span>
                                Monoclonal Antibodies
                            </h2>
                        </div>

                        <div class="content-card">
                            <p>One of the requirements for a highly sensitive and specific antigen-antibody reaction is to obtain pure antibody molecules, with high affinity and avidity for the antigen. Earlier techniques involved immunisation of animals with several repeated doses of antigen, followed by repeated bleeding to obtain the desired quantity of pure antibody.</p>
                            <p>Technologies have been developed to obtain monoclonal antibodies which are produced by the daughter cells (clones) of a single cell. One technique for the production of a pure, specific antibody by such a clone of cells is called a hybridoma technique. A hybrid of two types of cells is obtained which has a dual quality of being able to multiply indefinitely like a malignant cell; and to produce a specific antibody, like B-lymphocyte.</p>
                            
                            <p>The two types of cells used for the hybrid are:</p>
                            <p><strong>Multiple myeloma cells</strong> Multiple myeloma is a malignant tumour of antibody producing plasma cells, usually of undetermined specificity. The multiple myeloma cells selected for this technique, which can multiply indefinitely, also possess a very important defect. They are deficient in the enzyme hypoxanthine guanine phosphoribosyl transferase (HGPRT). Due to this defect they are unable to survive in the medium containing hypoxanthine, aminopterin and thymidine (HAT).</p>
                            <p><strong>Splenic cells of a mouse immunised with the specific antigen</strong> A mouse is immunised with the antigen for which the antibody is to be produced. The mouse responds by producing antibodies to many determinants or epitopes on the antigen injected. The mouse spleen is removed, minced and prepared as a single cell suspension. This should include the B-cell population which produces antibodies to the injected antigen. These B-cells cannot multiply indefinitely, but possess the enzyme HGPRT and can grow in HAT medium for some time.</p>

                            <h3>Fusion of Splenic B-cells with Multiple Myeloma Cells</h3>
                            <p>When these two types of cells are suspended in HAT medium in the presence of surfactants such as polyethelyne glycol (PEG), a spontaneous fusion occurs between some cells, resulting in a hybrid with the desired qualities of each type of cell. Only the hybrid cells are capable of growing indefinitely in HAT medium and produce antibodies to the desired antigen. The unfused myeloma cells will not be able to grow in the HAT medium because they lack HGPRT. The unfused antibody forming cells can grow for a short time in HAT medium, but die eventually. The hybrids formed by the fusion will be the only cells surviving indefinitely. This is the hybridoma technique (Fig. 4.2).</p>
                            <p>The hybrid cells are then screened to identify clones which produce the desired antibody. The selected cells or hybridomas may be maintained in cell culture or may be injected into the peritoneal cavity of a mouse for growth and subsequent antibody harvest.</p>

                            <figure class="content-figure" data-lightbox="true">
                                <div class="figure-image-wrapper">
                                    <img src="../assets/images/image-20251219-48e44177.jpeg" alt="Production of monoclonal antibodies by hybridoma technique" class="figure-image">
                                    <div class="figure-overlay">
                                        <span class="overlay-icon">üîç</span>
                                        <span class="overlay-text">Click to enlarge</span>
                                    </div>
                                </div>
                                <figcaption class="figure-caption">Fig. 4.2 Production of monoclonal antibodies by hybridoma technique</figcaption>
                            </figure>
                        </div>
                    </section>

                    <!-- Section 5: Precipitation -->
                    <section class="content-section" id="precipitation">
                        <div class="section-header">
                            <div class="section-number">05</div>
                            <h2 class="section-title">
                                <span class="title-icon">‚òÅÔ∏è</span>
                                Precipitation
                            </h2>
                        </div>

                        <div class="content-card">
                            <p>There are four essential factors that must be present for precipitation to occur. These are: antigen, antibody, an electrolyte and a means of mixing.</p>
                            <p>When a soluble antigen reacts with its antibody in the presence of an electrolyte such as normal saline, and then mixed by shaking, a visible antigen-antibody complex appears in the form of an insoluble precipitate.</p>
                            <p>Precipitation is perhaps the simplest method of detecting antigen-antibody reactions. Most antibodies are capable of precipitation. If the precipitate remains suspended in the form of floccules, the reaction is known as flocculation.</p>

                            <h3>Mechanism of precipitation</h3>
                            <p>By the lattice theory of precipitation, the precipitate is formed as a result of random, reversible reactions, where each antibody binds to more than one antigen, and vice versa; eventually forming a 'lattice' of antigen and antibody. Because it exceeds the critical volume for solubility, it appears as an 'insoluble precipitate'.</p>
                            <p>For an antigen-antibody reaction to result in the formation of a precipitate, several conditions are necessary:</p>
                            <ul class="enhanced-list">
                                <li class="list-item"><span class="list-marker"></span><span class="list-content">(i) Binding sites Both antigen and antibody molecules must possess multiple binding sites specific for each other.</span></li>
                                <li class="list-item"><span class="list-marker"></span><span class="list-content">(ii) Optimal concentration The relative concentration of antigen and antibody in the mixture must be optimal for that system. Usually it corresponds to approximately equivalent amounts of an antigen and antibody.</span></li>
                                <li class="list-item"><span class="list-marker"></span><span class="list-content">(iii) Other factors The degree of precipitation also depends on the electrolyte concentration, time and temperature of reaction, pH and mobility of the reactants in solution.</span></li>
                            </ul>

                            <h3>Prozone phenomenon</h3>
                            <p>If increasing quantities of antigen are added to the same amount of antibody in different tubes, precipitation is found to occur most rapidly and abundantly in the middle tubes, in which antigen and antibody are present in optimal or equivalent proportions (Fig. 4.3).</p>
                            
                            <figure class="content-figure" data-lightbox="true">
                                <div class="figure-image-wrapper">
                                    <img src="../assets/images/image-20251219-fa2defc1.jpeg" alt="Prozone (A), Zone of equivalence (B), and Postzone (C)" class="figure-image">
                                    <div class="figure-overlay">
                                        <span class="overlay-icon">üîç</span>
                                        <span class="overlay-text">Click to enlarge</span>
                                    </div>
                                </div>
                                <figcaption class="figure-caption">Fig. 4.3 Prozone (A), Zone of equivalence (B), and Postzone (C)</figcaption>
                            </figure>

                            <p>Similar results are obtained if varying amounts of antibody are added to a constant amount of antigen. If the amounts of precipitate in the different tubes in Fig. 4.3 are plotted on a graph, the resulting curve will show three phases (Fig. 4.4)</p>
                            <p>(i) The ascending portion called prozone or zone of antibody excess.<br>(ii) A peak, where antigen and antibody are in equivalent proportions. This zone is called the zone of equivalence.<br>(iii) The descending portion is called postzone or zone of antigen excess.</p>
                            <p>Prozone is important in some serological reactions when antibody is present in very high titres in the serum. If the test is performed by serially diluting the antibody and adding a constant amount of antigen, the first few tubes may not show precipitation due to excess of antibody molecules.</p>
                            <p>In such a test, the results may appear as</p>
                            <div class="code-block-wrapper">
                                <pre class="code-block"><code>Serum dilution
1:20 1:40 1:80 1:160 1:320 1:640 1:1280 1:2560
Precipitation
- - - ++ ++++ ++++ ++ -</code></pre>
                            </div>
                            <p>Therefore, if sufficiently wide range of antibody dilutions is not used, it may be wrongly interpreted as a negative test.</p>

                            <figure class="content-figure" data-lightbox="true">
                                <div class="figure-image-wrapper">
                                    <img src="../assets/images/image-20251219-d414cfee.jpeg" alt="Precipitation curve" class="figure-image">
                                    <div class="figure-overlay">
                                        <span class="overlay-icon">üîç</span>
                                        <span class="overlay-text">Click to enlarge</span>
                                    </div>
                                </div>
                                <figcaption class="figure-caption">Fig. 4.4 Precipitation curve</figcaption>
                            </figure>

                            <h3>Types of Precipitation Reaction</h3>
                            <p>Precipitation tests can be carried out either in solution or in gels.</p>

                            <h4>Precipitation in solution</h4>
                            <p>(i) Ring test In this simplest type of precipitation, antigen in solution is layered over a solution of antibody in a narrow tube or a capillary. Appearance of a precipitate at the junction of the two liquids indicates a positive test. Unknown antigens such as C-reactive proteins or streptococci can be identified and typed by using known antisera.</p>
                            <p>(ii) Slide test A drop of antigen and of antibody are mixed on a slide either on a shaker or manually for a few minutes. A positive test is indicated by the presence of floccules. This is known as slide flocculation test and is a common technique for VDRL (Venereal Disease Research Laboratory) test used in the diagnosis of syphilis. It can be used as a qualitative or quantitative test.</p>
                            <p>(iii) Tube test The tube test has a similar principle as the slide test. It can be used for quantitative estimation of antigen or antibody by serially diluting the unknown entity. The Kahn test for syphilis is an example of tube flocculation test. However, this test is outdated due to the advent of more specific and simpler tests. The tube flocculation test is also used for standardisation of toxins or toxoids.</p>

                            <h4>Precipitation in gel or Immunodiffusion</h4>
                            <p>Gels such as agar, agarose and polyacrylamide give good precipitation reaction because they help to stabilize liquids and prevent the formation of convection currents. The gels do not take part in the reaction and provide a mesh-like structure which allows free diffusion of soluble substances. When precipitate forms, the size of the complex exceeds the dimensions of the pore size of the gel, and the diffusion stops, leading to the formation of bands of precipitation.</p>
                            <p>When antigen and antibody are allowed to diffuse through a gel, the formation of precipitate indicates that both the reactants are homologous and are present in optimal proportions at the point of precipitation. This technique is known as immunodiffusion. There are two types of immunodiffusion: Passive and active. In passive immuno-diffusion, the reactions take place without the addition of electric field. They are simple to perform and do not require expensive equipment. However, they are slow and less sensitive. On the other hand, active immunodiffusion conducts immunodiffusion in an electric field which increases the sensitivity and reduces the time required for results, but requires special equipment.</p>
                            <p>Agar consists of a mixture of two polysaccharides, agarose and agaropectin, and is obtained by partial hydrolysis of a seaweed. The pore size of the medium depends on the concentration of agar. About 0.3 to 1.5 per cent agar gel concentrations are found to be optimum for most precipitation reactions. Agarose is prepared by removing agaropectin from agar.</p>
                            
                            <p><strong>Single diffusion techniques</strong> In single diffusion techniques, only one reactant, usually antigen, is allowed to diffuse into a medium containing a lower concentration of corresponding antibody. The single diffusion can be either in one dimension or two dimensions.</p>
                            
                            <p><strong>Single diffusion in one dimension (Oudin technique)</strong> This technique is performed in a tube. The antibody is mixed with agar at 60¬∞ C and allowed to cool in a tube. Antigen in solution, as the diffusing reactant, is overlaid on the cooled agar. In this system, the antigen can move only in one direction, downward. A band of precipitation will form where the antigen-antibody meet at optimal proportions. (Fig. 4.5) If the reactants contain more than one antigen or antibody, multiple precipitation bands appear independent of each other.</p>
                            <figure class="content-figure" data-lightbox="true">
                                <div class="figure-image-wrapper">
                                    <img src="../assets/images/image-20251219-3ead0b89.jpeg" alt="Oudin technique‚ÄîSingle diffusion in one dimension" class="figure-image">
                                </div>
                                <figcaption class="figure-caption">Fig. 4.5 Oudin technique‚ÄîSingle diffusion in one dimension</figcaption>
                            </figure>

                            <p><strong>Single diffusion in two dimensions (Radial immunodiffusion, RID)</strong> This involves the incorporation of one reagent, usually antibody, into the agar which is poured onto a flat plate. The corresponding reactant, the antigen, is placed in a circular well cut in the agar surface (Fig. 4.6). The antigen diffuses radially from the well into the surrounding agar, producing an advancing circular gradient. Ring shaped bands of precipitation form concentrically around the well. The diameter of the precipitation bands (haloes) is proportional to the concentration of the antigen in the well.</p>
                            <figure class="content-figure" data-lightbox="true">
                                <div class="figure-image-wrapper">
                                    <img src="../assets/images/image-20251219-6c8211dc.jpeg" alt="Radial immunodiffusion" class="figure-image">
                                </div>
                                <figcaption class="figure-caption">Fig. 4.6 Radial immunodiffusion</figcaption>
                            </figure>

                            <p><strong>Double diffusion techniques</strong> Double immunodiffusion techniques are those where both the antigen and the antibody are allowed to diffuse through a matrix of neutral gel. Like single diffusion, it can be in one dimension (in tubes) or two dimensions (on a plate).</p>
                            <p>Double diffusion in one dimension In this technique, the antibody is incorporated in gel and allowed to set in a tube. Above this is placed a column of plain agar. Antigen in gel is layered on top of the plain agar. The antigen and antibody move towards each other through the column of plain agar. A band of precipitation is formed where they meet at optimum proportion (Fig. 4.7).</p>
                            <figure class="content-figure" data-lightbox="true">
                                <div class="figure-image-wrapper">
                                    <img src="../assets/images/image-20251219-fe1e63d9.jpeg" alt="Double diffusion in one dimension" class="figure-image">
                                </div>
                                <figcaption class="figure-caption">Fig. 4.7 (Usually depicts double diffusion in tube)</figcaption>
                            </figure>

                            <p>Double diffusion in two dimensions (Ouchterlony Technique) This is a highly versatile system for identifying and characterising antigen-antibody systems. A 1% agarose gel is prepared on a flat surface. Wells are cut into this medium, the distance and configuration of wells varies with each system. In its simplest form, two wells are cut as shown in Figure 4.8. Reacting antigen and antibody solutions are placed in respective wells. The plate is then placed in a moist chamber either at 4¬∞C or 37¬∞C. The reaction is faster at 37¬∞C, but the bands are sharper at 4¬∞C. During incubation, each reactant diffuses radially from the point of application. The precipitin bands appear at approximately the point of equivalence, perpendicular to the axis line between the points of application (Fig. 4.8 (i)).</p>
                            <p>One of the advantages of this technique is that the reactants in the wells diffuse radially, and therefore, are capable of reacting in any direction. This helps to compare different antigens or antisera directly for their identity, non-identity or relatedness (Fig. 4.8 (ii)). Various different sizes, shapes and configurations of wells can be used in this technique. A circular central well and equidistant satellite wells around it is the most commonly used pattern.</p>
                            <p>The selected pattern, the template, is drawn on a paper which is placed under the gel plate. The wells are then cut according to the template, and filled with the desired reactants. For example, a known antiserum in the centre and antigen solution to be tested in the surrounding wells. At the end of appropriate incubation period, the plate is examined for the lines of precipitation. The lines are very fine and should be observed in diffused light (Fig. 4.9).</p>
                            <p>The types of precipitation bands commonly observed are:</p>
                            <p>(i) The reaction of identity where the lines are continuous from one well to the next (Fig. 4.8 ii A).<br>(ii) The reaction of non-identity where the lines cross each other (Fig. 4.8 ii B) and<br>(iii) The reaction of partial identity where a spur is formed at the junction of the precipitation bands (Fig. 4.8 ii C).</p>
                            <figure class="content-figure" data-lightbox="true">
                                <div class="figure-image-wrapper">
                                    <img src="../assets/images/image-20251219-1901b83f.jpeg" alt="Ouchterlony technique patterns" class="figure-image">
                                </div>
                                <figcaption class="figure-caption">Fig. 4.8 Ouchterlony technique</figcaption>
                            </figure>

                            <p>Elek's test is a modification of the Ouchterlony technique. It is used to detect toxin producing strains of <em>Corynebacterium diphtheriae</em>. A strip of filter paper impregnated with diphtheria antitoxin (500 to 1000 units/ml) is embedded in the centre of an agar gel. A known toxin producing strain of <em>C. diphtheriae</em> and the strain isolated from a patient are streaked separately at right angle to the filter paper strip. If the isolate produces toxin, a line of precipitation is seen which merges with that produced by the control strain, proving identity.</p>

                            <h4>Electroimmunodiffusion or Active Immunodiffusion Techniques</h4>
                            <p>Electroimmunodiffusion or active immunodiffusion combines electrophoresis with immunodiffusion techniques. Electrophoresis is the use of electric current to induce the migration and separation of charged ions in an electric field. The reactants in these procedures are stabilized by a porous material such as agar, agarose or cellulose acetate. Agarose and cellulose acetate are stabilized by a porous material such as agar, agarose or cellulose acetate.</p>
                            <p>Migration of proteins in an electric field is affected by the charge, size and shape of particles; the concentration and pH of the solvent; the temperature and viscosity of the medium; and intensity of the electric field. Like immunodiffusion, electroimmunodiffusion can occur as single or double diffusion in one or two dimensions. The various techniques are briefly described here.</p>
                            
                            <p>Counterimmunoelectrophoresis (CIEP) This is a double diffusion in one dimension which is based on the principle of endosmosis. Commercially available agar forms a gel with a negative electrical charge. When such a gel is used for electrophoresis, a current is established in the direction opposite to the electrophoretic migration. In a gel at pH 8.2, immunoglobulins which are electrically almost neutral, move in the direction opposite to that of the electric current, because of this electro-endosmotic flow. If the antigen is placed near the cathode as compared to the antiserum, the antigen will move towards the anode (+) along with the electric current and the antibody will move towards the cathode (-) due to endosmosis (Fig. 4.10). A precipitate will form as they meet.</p>
                            <figure class="content-figure" data-lightbox="true">
                                <div class="figure-image-wrapper">
                                    <img src="../assets/images/image-20251219-c8500f82.jpeg" alt="Counterimmunoelectrophoresis (CIEP)" class="figure-image">
                                </div>
                                <figcaption class="figure-caption">Fig. 4.10 Counterimmunoelectrophoresis (CIEP)</figcaption>
                            </figure>

                            <p>Immunoelectrophoresis Immunoelectrophoresis is an ingenious method of analyzing and identifying serum proteins by a combination of electrophoretic protein separation followed by immunodiffusion. Serum is placed in a well in an appropriate medium such as cellulose acetate, agar or agarose; at a suitable pH (usually 0.05 M Veronal buffer, pH 8.6). It is electrophoresed at about 50 volts, 2.5 milliamperes per slide for a period of 45 minutes to 4 hours. This separates the constituents of the serum according to their electrophoretic mobilities. Albumin, the most negatively charged in basic buffers, moves the farthest distance towards the anode, followed by Œ±1, Œ±2, Œ≤ and Œ≥ globulins (Fig. 4.11).</p>
                            <p>After electrophoresis, troughs are cut on each side of, and parallel to, the line of electrophoresis. The troughs are filled with antibody to human serum, for the detection of an abnormal component in the serum. During incubation, double immuno-diffusion fusion takes place. The antiserum diffuses perpendicular to the trough, and each serum protein diffuses outward from its point of electrophoresis. Precipitation bands appear at the equivalence points, and can be identified by their shape and position (Fig. 4.11).</p>
                            <figure class="content-figure" data-lightbox="true">
                                <div class="figure-image-wrapper">
                                    <img src="../assets/images/image-20251219-8f6bb79a.jpeg" alt="Immunoelectrophoresis" class="figure-image">
                                </div>
                                <figcaption class="figure-caption">Fig. 4.11 Immunoelectrophoresis</figcaption>
                            </figure>

                            <p>Rocket Electrophoresis and Crossed Immunoelectrophoresis These are two more modifications of immunoelectrophoresis. In rocket electrophoresis, serum is separated electrophoretically into its components. In the second stage, it is allowed to diffuse into the antibody incorporated in the gel to form precipitation peaks. Since the pattern resembles a spike or a rocket, it is called rocket electrophoresis.</p>
                            <p>In crossed electrophoresis, an electric current is applied at right angles to the first run to form precipitation peaks in the antibody containing gel. The area of the peak is proportional to the concentration of the antigen (Fig. 4.12).</p>
                            <figure class="content-figure" data-lightbox="true">
                                <div class="figure-image-wrapper">
                                    <img src="../assets/images/image-20251219-4005d03e.jpeg" alt="Crossed immunoelectrophoresis" class="figure-image">
                                </div>
                                <figcaption class="figure-caption">Fig. 4.12 Crossed immunoelectrophoresis</figcaption>
                            </figure>
                        </div>
                    </section>

                    <!-- Section 6: Agglutination -->
                    <section class="content-section" id="agglutination">
                        <div class="section-header">
                            <div class="section-number">06</div>
                            <h2 class="section-title">
                                <span class="title-icon">üî¥</span>
                                Agglutination
                            </h2>
                        </div>

                        <div class="content-card">
                            <p>Agglutination is the observable clumping which occurs when a particulate antigen is mixed with its antibody. This reaction takes place at a suitable temperature and pH, and in presence of an electrolyte such as sodium chloride.</p>

                            <h3>Mechanism of agglutination</h3>
                            <p>The mechanism of agglutination is based on the same principle as that of precipitation i.e. the formation of lattice by antigen and antibody combining in optimal proportions. However, due to the particulate nature of the antigen in agglutination, the reaction takes place in two phases, primary and secondary.</p>
                            <p>In the primary phase, an antibody molecule binds with the antigenic determinant on the particulate antigen. In the secondary phase, the same antibody molecule must bind to an antigenic determinant on another particle of the antigen to facilitate formation of a lattice (Fig. 4.13). Viscosity of the environment and better exposure of antigenic determinants enhance the secondary phase of agglutination. Therefore, addition of agents such as albumin or enzymes (e.g. papain) may be needed to improve the secondary reaction.</p>
                            <figure class="content-figure" data-lightbox="true">
                                <div class="figure-image-wrapper">
                                    <img src="../assets/images/image-20251219-1c5416db.jpeg" alt="Primary and secondary phases of agglutination reaction" class="figure-image">
                                </div>
                                <figcaption class="figure-caption">Fig. 4.13 Primary and secondary phases of agglutination reaction</figcaption>
                            </figure>

                            <h3>Role of an electrolyte in agglutination</h3>
                            <p>Because particulate antigens have net electrostatic charges on their surface, they tend to repel each other. The net effect of this is that the particles are kept apart. An antibody molecule, therefore, may find it difficult to bind to two particles at the same time. Electrolytes such as saline neutralise negative charges and tend to nullify the repulsive forces between antigen molecules. This allows them to come closer and facilitate multiple binding by one antibody molecule.</p>

                            <h3>Complete and Incomplete (blocking) antibodies</h3>
                            <p>Antibodies involved in <em>in vitro</em> agglutination reactions are regarded to be complete if they are capable of both primary and secondary stage interactions with antigen in a normal saline solution. IgM antibodies act as complete antibodies due to their high valency and high molecular weight. Incomplete antibodies bring about primary but not secondary binding. Most incomplete antibodies are IgG by nature. The presence of IgG in test samples may have the effect of blocking the agglutinating ability of IgM by occupying the necessary binding sites on the antigen (Fig. 4.14).</p>
                            <p>As in precipitation, prozone phenomenon is also observed in agglutination reactions due to the presence of antibodies in high concentration. The prozone phenomenon can however, be overcome by using a wider range of dilutions of antibody in the test. This eliminates false negative results.</p>
                            <p>The presence of blocking antibodies in low titres may also be responsible for the absence of agglutination. The effect of blocking or incomplete antibodies may be overcome by using hypertonic (5%) saline instead of isotonic (0.85%) normal saline, by the addition of albumin (22% bovine albumin in saline) to the test or by the use of antiglobulin (Coomb's) reagent.</p>
                            <figure class="content-figure" data-lightbox="true">
                                <div class="figure-image-wrapper">
                                    <img src="../assets/images/image-20251219-6167109a.jpeg" alt="Effect of blocking antibodies" class="figure-image">
                                </div>
                                <figcaption class="figure-caption">Fig. 4.14 Effect of blocking antibodies</figcaption>
                            </figure>

                            <h3>Types of Agglutination Tests</h3>
                            <p>Agglutination reactions have the advantage of being (i) simple to perform (ii) relatively sensitive (iii) having a wide range of applications. Agglutination tests can be qualitative or quantitative.</p>
                            
                            <p><strong>Slide agglutination tests</strong> These are rapid techniques which can be easily performed on a slide or agglutination tile. The reaction can be read within seconds or minutes. The slide tests are classically qualitative but can be adapted for quantitative estimations.</p>
                            <p>These tests may be either active or passive agglutination reactions. Active (or direct) agglutination tests are those which use the antigen where the antigenic determinant is inherent to the particle itself. Passive (or indirect) agglutination tests use inert particles coated with soluble antigens. By passive agglutination, even soluble antigens can be used for agglutinations tests. The inert particles commonly employed are polystyrene latex, bentonite, charcoal or red blood cells.</p>
                            
                            <p><strong>Active agglutination</strong> When a smooth, uniform suspension of a particulate antigen, such as bacteria, prepared in a drop of saline on a slide or a tile, is mixed with a drop of antiserum, agglutination takes place if the antigen and antibody are homologous. Gently rocking the slide facilitates the reaction, which appears instantly or within a few seconds. Care should be taken to see that the clumping is not due to autoagglutination which is false clumping not due to antigen-antibody reaction. A control consisting of the antigen suspension in saline should also be prepared on the same slide.</p>
                            <p>Direct slide agglutination is a routine procedure for the identification and serotyping of bacterial isolates from clinical specimens using known specific antisera. Examples are <em>Salmonella</em> and <em>Shigella</em> slide agglutination tests.</p>
                            
                            <p><strong>Passive agglutination</strong> Examples of passive agglutinators slide tests are:</p>
                            <p>(i) Tests using latex particles Passive agglutination can be used for the diagnosis of arthritis. In rheumatoid arthritis, (RA) an autoantibody called RA factor appears in the patient's serum and acts as an antibody to gamma globulin. In the test, latex particles coated with gamma globulin are mixed with patient's serum. Agglutination indicates the presence of RA factor in patient's serum. Polystyrene latex particles are used in many other tests such as test for the detection of antibody to streptolysin O of streptococci by coating the latex particles with the streptococcal antigen.</p>
                            <p>(ii) Tests using red blood cells Tests using red blood cell agglutination are called haemagglutination tests. Treponema pallidum haemagglutination (TPHA) test uses chicken erythrocytes coated with an extract of T. pallidum. These red cells are agglutinated by antibody in the serum of a patient with syphilis.</p>
                            <p>(iii) Tests using carbon particles Carbon particles mixed with cardiolipin antigen are used in the rapid plasma reagin (RPR) card test. Patient's serum is mixed with this antigen. Agglutination reaction is rendered easily visible by the presence of carbon particles and indicates the presence of antibodies in patient's serum. This is a screening test for cardiolipin antibodies in the sera of patients suffering from syphilis. It is a non-specific screening test.</p>
                            
                            <p><strong>Tube agglutination test</strong> This is a standard method for the quantitative estimation of antibodies. It is more sensitive than slide test. To serial dilutions of patient's serum in tubes, a constant amount of known antigen is added. The highest dilution showing agglutination indicates the antibody titre for the antigen tested. Tube agglutination tests are routinely employed for serodiagnosis of typhoid, brucellosis and typhus fever. A four fold rise in antibody titre in paired sera indicates active infection and is more diagnostic than a single result.</p>
                            
                            <p><strong>Reversed passive agglutination test</strong> Reversed passive agglutination involves adsorption of antibody, instead of antigen, on to inert carrier particles. The tests are useful for the detection of antigens, using known antisera on carrier particles. For example, reversed passive haemagglutination (RPHA) assays are available for the detection of antigens such as rubella and measles. Inert particles such as polystyrene latex can be used for the detection of soluble bacterial antigens in clinical specimens such as CSF or for viral antigens in specimens such as stool.</p>
                            <figure class="content-figure" data-lightbox="true">
                                <div class="figure-image-wrapper">
                                    <img src="../assets/images/img-42.jpeg" alt="(A) Passive and (B) Reversed passive agglutination" class="figure-image">
                                </div>
                                <figcaption class="figure-caption">Fig. 4.15 (A) Passive and (B) Reversed passive agglutination</figcaption>
                            </figure>

                            <p><strong>Coagglutination (COAG) tests</strong> Coagglutination is a modification of reversed passive agglutination where a pretreated, 'stabilized' cell of Staphylococcus aureus is used as a carrier particle for antibodies. COAG is based on the principle that most strains of Staphylococcus aureus possess on their surfaces a substance called protein A which is capable of binding IgG molecules nonspecifically through the Fc region. When mixed with the specific antigen, it will bind with the antibody molecules attached to protein A on staphylococci, resulting in clumping of bacteria. This indicates a positive test (Fig. 4.16). Reagents for coagglutination are commercially available.</p>
                            <figure class="content-figure" data-lightbox="true">
                                <div class="figure-image-wrapper">
                                    <img src="../assets/images/img-43.jpeg" alt="Coagglutination" class="figure-image">
                                </div>
                                <figcaption class="figure-caption">Fig. 4.16 Coagglutination</figcaption>
                            </figure>

                            <p><strong>Antiglobulin mediated agglutination test (Coomb's test)</strong> The Coomb's test was originally devised for the detection of incomplete Rh-antibodies which do not agglutinate Rh-positive erythrocytes in saline. When the serum of Rh-negative mother, containing such incomplete IgG antibodies to Rh-antigen are mixed with Rh-positive red cells, the Rh-antibody binds to the surface of the red cells, without agglutinating them. Such red cells are called 'sensitised' red cells. When such sensitised cells are treated with antiglobulin or Coomb's serum, the cells coated with Rh-antibody are agglutinated by this 'antibody to the antibody' (Fig. 4.17).</p>
                            <p>The Coomb's reagent is an antibody to human immunoglobulin raised in animals such as rabbit. It can be used to detect incomplete or non-agglutinating antibodies against many antigens. It can also detect false negative tests due to blocking antibodies.</p>
                            <p>The Coomb's test can be either direct or indirect. The direct Coomb's test can detect the cells which are 'sensitised' with the blocking antibodies 'in vivo'. Addition of a drop of the Coomb's reagent to such sensitised cells shows visible agglutination. The red cells sensitised with incomplete Rh-antibodies are present in neonates suffering from haemolytic disease of the new born (HDN) due to Rh incompatibility.</p>
                            <p>The indirect Coomb's tests detects incomplete antibodies in patient's serum. The sensitisation of a known antigen is performed 'in vitro' by the antibody in the patients serum. Addition of the Coomb's reagent results in agglutination. The indirect Coomb's test is useful for the detection of incomplete antibodies in cases such as an Rh-negative mother or in brucellosis.</p>
                            <figure class="content-figure" data-lightbox="true">
                                <div class="figure-image-wrapper">
                                    <img src="../assets/images/img-44.jpeg" alt="Antiglobulin test" class="figure-image">
                                </div>
                                <figcaption class="figure-caption">Fig. 4.17 Antiglobulin test</figcaption>
                            </figure>
                        </div>
                    </section>

                    <!-- Section 7: Complement Fixation Test -->
                    <section class="content-section" id="cft">
                        <div class="section-header">
                            <div class="section-number">07</div>
                            <h2 class="section-title">
                                <span class="title-icon">üîå</span>
                                Complement Fixation Test [CFT]
                            </h2>
                        </div>

                        <div class="content-card">
                            <p>Complement is 'activated' in vivo when it is 'fixed' to an antigen-antibody complex. When activated, the complement can initiate a series of biological reactions in the body through the activities of various components of the complement cascade. These activities include lysis of antigens such as bacteria or red cells, killing of bacteria, immobilization of motile bacteria and promotion of phagocytosis.</p>
                            <p>In the complement fixation test, complement is fixed to an antigen-antibody complex without any observable biological activity. For this reason, an indicator system is included in the test to detect fixation or non-fixation of complement. In the absence of either antigen or antibody, complement will not be fixed. The CFT is mainly used for the detection of antibodies in patient samples.</p>
                            
                            <p><strong>Principle of CFT</strong> Complement fixation test involves a test system and an indicator system, both of which are capable of activating complement. The test system consists of patient's serum and a known antigen. The indicator system consists of sheep red cells coated with antibody to sheep red cells. These cells will lyse in presence of complement.</p>
                            <p>CFT consists of the following steps:</p>
                            <p>(i) A known antigen and patient's serum (which may contain antibody to the antigen) are reacted with standardized, limited amount of reagent complement. If specific, complement activating antibody is present in the serum, complement will be activated or 'fixed' by the antigen-antibody complex. On the other hand, if there is no antibody in the patient's serum, there will be no antigen-antibody complex, and therefore, complement will not be 'fixed', but will remain free.</p>
                            <p>(ii) In the second step, the indicator system is added to the test. If complement is fixed in the first step due to the presence of antibody in patient's serum, there will be no complement left to 'fix' to the indicator system. If there is no antibody in patient's serum, there will be no antigen-antibody complex, and therefore, complement will not be fixed. This 'unfixed' complement will bring about the lysis of red cells. Therefore, no lysis of sheep red cells indicates presence of antibody in the test serum; and lysis of sheep red cells shows a negative test for antibody in the serum. (Fig. 4.18).</p>
                            
                            <p>CFT is a complex procedure which requires five reagents. Accurate results depend on appropriate standardization of each reagent involved.</p>
                            <p><strong>Antigen</strong> The antigen may be soluble or particulate.</p>
                            <p><strong>Antiserum</strong> The patient's serum, which has to be tested for the presence of antibody, should be inactivated at 56 ¬∞C for 30 minutes to destroy its complement activity so that it will not interfere in the test. The inactivation also removes non-specific inhibitors of complement which may be present.</p>
                            <p><strong>Complement</strong> The commonest source of fresh complement is the guinea-pig-serum. As complement is easily destroyed by heat, the serum should be collected just before use. It can be preserved either by freezing or chemically by Richardson's method. Complement is also available commercially. Complement should be standardised for its haemolytic activity. One unit of minimum haemolytic dose (MHD) of complement is the highest dilution of the complement that lyses one unit volume of washed sheep red cells in the presence of excess of haemolysin (amboceptor) in 30 or 60 minutes, at 37¬∞C.</p>
                            <p><strong>Sheep red cells</strong> A washed, 5% suspension of fresh sheep red cells should be used.</p>
                            <p><strong>Haemolysin (amboceptor)</strong> This is an antibody to sheep red cells raised in rabbit. This is standardised as MHD which is the highest dilution of the inactivated amboceptor that lyses one unit volume of sheep red cells in the presence of excess of complement within 30 or 60 minutes at 37 ¬∞C.</p>
                            
                            <div class="callout callout--note">
                                <div class="callout-header">
                                    <span class="callout-icon">‚ÑπÔ∏è</span>
                                    <h4 class="callout-title">Note</h4>
                                </div>
                                <div class="callout-content">
                                    <p>It is necessary to run known positive and negative controls with each CFT.</p>
                                </div>
                            </div>

                            <figure class="content-figure" data-lightbox="true">
                                <div class="figure-image-wrapper">
                                    <img src="../assets/images/img-45.jpeg" alt="Complement fixation test - Positive Result" class="figure-image">
                                </div>
                                <div class="figure-image-wrapper" style="margin-top: 1rem;">
                                    <img src="../assets/images/img-46.jpeg" alt="Complement fixation test - Negative Result" class="figure-image">
                                </div>
                                <figcaption class="figure-caption">Fig. 4.18 Complement fixation test</figcaption>
                            </figure>

                            <h3>Applications of CFT</h3>
                            <p>Complement fixation tests are more cumbersome to perform, but much more sensitive than precipitation and agglutination tests. They are less sensitive than other serological tests such as radioimmunoassays, enzyme immunoassays or immunofluorescence tests. They are very valuable in the diagnosis of some viral, rickettsial and mycotic infections.</p>
                        </div>
                    </section>

                    <!-- Section 8: Neutralisation -->
                    <section class="content-section" id="neutralisation">
                        <div class="section-header">
                            <div class="section-number">08</div>
                            <h2 class="section-title">
                                <span class="title-icon">üõë</span>
                                Neutralisation Tests
                            </h2>
                        </div>

                        <div class="content-card">
                            <p>Neutralisation tests are based on the principle that specific antibodies are able to neutralize biological effects of viruses, toxins and enzymes. They can be used for the detection of either antigen or antibody.</p>

                            <h3>Virus neutralisation tests</h3>
                            <p>When grown in various culture systems, viruses produce biological effects. Neutralisation of these effects by a specific antibody is used in the identification of viruses. Two examples of virus neutralisation tests are described below:</p>
                            
                            <p>(i) Neutralization of cytopathic effect (CPE)</p>
                            <p>Neutralising antibodies react with their homologous virus by attaching to certain critical antigenic determinants on the virus particle. This renders the virus incapable of initiating infection in susceptible host cells. Viruses such as poliovirus produce characteristic cytopathic effects when grown in appropriate tissue culture systems. Patient's serum to be tested for antibodies to poliovirus is mixed with a known suspension of polio virus. After appropriate incubation for antigen-antibody binding to occur, the mixture is inoculated into a susceptible cell line. After incubation, absence of CPE in the cell line, shows that the patient's serum contains neutralising antibody to polio virus. CPE will be observed in the absence of antibody.</p>
                            <p>CPE neutralisation test can also be performed for the identification of isolated virus by treating it with a known antibody before inoculation into a susceptible cell line.</p>
                            
                            <p>(ii) Haemagglutination inhibition (HAI) test</p>
                            <p>Some viruses have the ability to induce haemagglutination when combined in vitro with erythrocytes from specific animal sources. For example, rubella virus can agglutinate red cells from newborn chickens. However, it should be borne in mind that haemagglutination by viruses is not an antigen-antibody reaction, but a biological effect due to receptors on their surfaces for red cells. This activity can be neutralised by neutralising antibody to the virus.</p>
                            <p>Antibody to a haemagglutinating virus can be detected by first reacting patient serum with the virus. After appropriate incubation, the red cell suspension of susceptible species is added to this mixture. If inhibiting antibody is present in the patient's serum, haemagglutination will not occur. It is possible to determine the HAI titre of antibody by preparing serial dilutions of the patient's serum and mixing with a constant amount of viral suspension.</p>

                            <h3>Toxin neutralisation tests</h3>
                            <p>Exotoxins produced by some bacteria such as <em>Corynebacterium diphtheriae</em> or <em>Clostridium tetani</em>, are strongly antigenic and induce the formation of neutralising antibodies (antitoxins) in their host. Effects of toxin can be neutralised by antitoxins and can be demonstrated by either in vivo or in vitro tests. Neutralisation tests can be performed in vivo in animals by injecting into them a mixture of toxin and patient's serum. If an antitoxin is present in patient's serum, it should prevent disease or death of the animals.</p>
                            <p>An example of toxin neutralisation test in vitro is the Nagler reaction which is used for identification of toxin producing <em>Clostridium perfringens</em> from clinical specimens. The Œ±-toxin of the pathogen produces an opalescence in medium containing egg-yolk. For the test, half of the petri dish containing egg-yolk agar is smeared with the antitoxin. The isolate is inoculated in a streak across the plate, starting from antitoxin-free area to the one seeded with antitoxin. After anaerobic incubation at 37¬∞C, the colonies of <em>C. perfringens</em> in the antitoxin-free area show a zone of opacity while those on the antitoxin portion show no opacity due to neutralisation of the toxin (lecithinase) by the antitoxin.</p>

                            <h3>Enzyme Inhibition tests</h3>
                            <p>Enzymes are proteins which act on their specific substrates and bring about chemical changes. Due to their chemical nature, enzymes can also be antigenic. Enzyme inhibition tests make use of this phenomenon by reacting a specific antibody with its enzyme antigen which inhibits the enzyme's ability to react with its substrate.</p>
                            <p>The best example of this phenomenon is the detection of antistreptolysin O (ASO), which is an antibody to the haemolytic enzyme Streptosin O. Patient's serum which may contain the antibody is serially diluted and mixed with a constant amount of streptolysin O, followed by addition of a suspension of red blood cells. Neutralisation of streptolysin O by ASO will result in inhibition of haemolysis of the added red cells.</p>
                        </div>
                    </section>

                    <!-- Section 9: Labelling Techniques -->
                    <section class="content-section" id="labelling">
                        <div class="section-header">
                            <div class="section-number">09</div>
                            <h2 class="section-title">
                                <span class="title-icon">üè∑Ô∏è</span>
                                Labelling Techniques
                            </h2>
                        </div>

                        <div class="content-card">
                            <p>There are four types of techniques which involve labelling or tagging either antigen or antibody in order to detect or quantitate the presence of one of the reactants. These are:</p>
                            <ul class="enhanced-list">
                                <li class="list-item"><span class="list-marker"></span><span class="list-content">A. Immunofluorescence assay (IFA)</span></li>
                                <li class="list-item"><span class="list-marker"></span><span class="list-content">B. Radioimmunoassay (RIA)</span></li>
                                <li class="list-item"><span class="list-marker"></span><span class="list-content">C. Enzymeimmunoassay (EIA) and</span></li>
                                <li class="list-item"><span class="list-marker"></span><span class="list-content">D. Western Blot (Immunoblot)</span></li>
                            </ul>

                            <h3>Immunofluorescence assays</h3>
                            <p>Fluorescence is the phenomenon exhibited by certain molecules or compounds known as fluorochromes. They absorb light energy of one wave length and emit the light energy of another wave length. If a fluorochrome receives the invisible ultra violet light, it will emit a light within the visible spectrum, for example, green.</p>
                            <p>Fluorescein is used as an isothiocyanate which makes its subsequent attachment to antigen or antibody easier. When fluorescein isothiocyanate is combined with antigen or antibody, it is referred to as a conjugate. Fluorescein conjugated with various antigens and antibodies are commercially available. It is necessary to determine the appropriate dilution of the conjugate for IFT to avoid non-specific staining. Optimum dilution is determined by trying different dilutions on a known positive antigen or antibody for each lot of conjugate.</p>
                            <p>The phenomenon of fluorescence, when used in antigen-antibody reactions, is known as immunofluorescence.</p>
                            
                            <h4>Application of Immunofluorescence (IFA)</h4>
                            <p>The IFA can be either on solid-phase (heterogeneous) or in liquid-phase (homogeneous). In the clinical laboratory, solid-phase IFAs are more commonly performed. There are three solid-phase techniques which are most frequently used. They are direct IFA, indirect IFA and sandwich IFA.</p>
                            
                            <p>(i) Direct Immunofluorescence Assay Direct IFA can be used to identify an unknown antigen which can be attached to a solid phase, such as a microscope slide.</p>
                            <p>The clinical specimen which may contain a specific antigen is smeared on a glass slide. The air-dried smear is fixed with acetone for 1‚Äì2 minutes. This fixed antigen is then reacted with a known, fluorescein labelled antibody. Evidence of fluorescence in the smear under fluorescence microscope indicates a positive test for antigen in the specimen. (Fig. 4.19A).</p>
                            <p>Direct IFA is useful for rapid identification of causative agents such as bacteria; viruses and fungi in clinical specimens.</p>
                            <p>A disadvantage of this method is that a separate, specific conjugate needs to be prepared for every antigen to be tested and is expensive.</p>
                            
                            <p>(ii) Indirect Immunofluorescence Assay In the indirect IFA, the reacting antigen and antibody are both unlabelled. The antigen-antibody complex is then detected by an anti-human immunoglobulin labelled with fluorescein isothiocyanate (FIT). (Fig. 4.19B). The indirect IFA can be used to detect either unknown antigen or antibody. The advantage of the indirect test is that the same conjugate with anti-human globulin can be used for all the tests.</p>
                            
                            <p>(iii) Sandwich Immunofluorescence Assay Unknown antigen in the specimen can also be detected by the sandwich technique. Known unlabelled antibody, specific for the antigen, is attached to the solid phase. The specimen, which is being tested for the antigen in the medium, is then added.</p>
                            <p>After incubation and washing, FIT labelled specific antibody is added. If fluorescence is detected, it is an indication of the presence of antigen in the specimen. Here, the antigen is 'sandwiched' between unlabelled and labelled antibody. (Fig. 4.19C).</p>
                            <figure class="content-figure" data-lightbox="true">
                                <div class="figure-image-wrapper">
                                    <img src="../assets/images/img-47.jpeg" alt="Immunofluorescence (A) Direct" class="figure-image">
                                    <img src="../assets/images/img-48.jpeg" alt="Immunofluorescence (B) Indirect" class="figure-image">
                                    <img src="../assets/images/img-50.jpeg" alt="Immunofluorescence (C) Sandwich" class="figure-image">
                                </div>
                                <figcaption class="figure-caption">Fig. 4.19 Immunofluorescence (A) Direct, (B) Indirect and (C) Sandwich techniques</figcaption>
                            </figure>

                            <div class="callout callout--warning">
                                <div class="callout-header">
                                    <span class="callout-icon">‚ö†Ô∏è</span>
                                    <h4 class="callout-title">Important</h4>
                                </div>
                                <div class="callout-content">
                                    <p>In all immunofluorescence assays, it is essential to run known positive and negative controls with each test. This helps to guard against non-specific fluorescence, which may lead to false-positive results.</p>
                                </div>
                            </div>

                            <h3>Radioimmunoassay (RIA)</h3>
                            <p>Radioimmunoassay or RIA is another labelling technique used for the detection of antibody, or more commonly, antigen. It uses a radioactive label or tracer to assess the concentration of biological molecules. Tritium ($H^3$), $I^{131}$ or $I^{125}$ are commonly used as tracers.</p>
                            <p>RIA makes use of the principle of competitive binding between radiolabelled and unlabelled molecules of antigen to bind with a high affinity, specific antibody. The amount of unlabelled antigen present in the specimen is measured by its competitive effect on the labelled antigen for limited antibody sites.</p>
                            
                            <h4>RIA for antigen detection</h4>
                            <p>The antigen to be detected in the clinical specimen, e.g. hepatitis-B surface antigen (HBs Ag) is radio-labelled with $I^{125}$.</p>
                            <p>The labelled antigen is allowed to react with the known specific antibody. The proportion of antigen-antibody is such that about 70% of antibody sites are bound by labelled antigen. A clinical specimen, containing the antigen under test, is added to this mixture. If present, the unlabelled antigen from the specimen competes with the labelled antigen for binding sites and may displace some labelled antigen.</p>
                            <p>After appropriate incubation period, labelled antigen bound to the antibody is separated from the unbound labelled antigen (see below). The change in the amount of radioactivity due to unlabelled antigen is measured using a scintillation counter (Fig. 4.20).</p>
                            <p>A standard curve is constructed with radioactivity obtained by adding various known amounts of unlabelled antigen to a constant amount of antibody-labelled antigen mixture. From this curve, the amount of antigen can be assessed from its radioactivity with the help of the standard curve.</p>
                            <figure class="content-figure" data-lightbox="true">
                                <div class="figure-image-wrapper">
                                    <img src="../assets/images/img-53.jpeg" alt="RIA competitive binding assay" class="figure-image">
                                </div>
                                <figcaption class="figure-caption">Fig. 4.20 RIA competitive binding assay</figcaption>
                            </figure>

                            <h4>RIA for antibody detection</h4>
                            <p>The classic RIA procedure for antigen detection can be varied for the detection of antibody. In this case, the antibody, radiolabelled and unlabelled, competes for the antigen.</p>

                            <h4>Techniques for the separation of bound and free labelled molecules</h4>
                            <p>It is essential to separate free and bound radioactive molecules at the end of the reaction before the measurement of radioactivity. The following techniques can be used for this separation:</p>
                            <p>(i) Farr technique The labelled antigen combined with antibody can be separated from the free labelled antigen by using 50% ammonium sulphate solution. This selectively precipitates immunoglobulin. This method is applicable only to antigens with molecular weight &gt; 30,000.</p>
                            <p>(ii) Use of anti-globulin serum The antigen bound to the antibody can be precipitated by the use of antiglobulin serum which will bind with the antibody molecules and form a precipitate.</p>
                            <p>(iii) Use of staphylococcal protein A Staphylococcal protein A has a high affinity for the Fc portion of immunoglobulin G (IgG), bringing about its precipitation along with bound antigen. This method can be employed only if IgG antibodies are used in the test.</p>
                            <p>(iv) Solid phase RIA or Immunoradiometric Assay (IRMA) This is an RIA competitive binding assay on a solid phase such as the wall of a test tube, microtitre well or bead. Attachment of the radiolabe antigen to the solid phase facilitates separation of bound and free radiolabelled reactants merely by washing.</p>

                            <h4>Advantages and disadvantages of RIA</h4>
                            <p>RIA is a very sensitive and specific method for the assay of various antigens and antibodies. Substances such as hormones or drugs, which can be antigenic in laboratory animals and produce specific antibody can be assayed by this method. With increasing use of monoclonal antibodies, RIA is proving to be very useful. Major disadvantages of RIA are the use of radioactive compounds which have a limited shelf-life and need special staff training for handling them. Counting radioactive emissions requires expensive equipment. If the radiation is not well monitored, it can be a potential health hazard.</p>

                            <h3>Enzyme Immunoassay (EIA)</h3>
                            <p>Enzymes are molecules which function as catalysts for certain biochemical reactions. A small amount of enzyme can react with much larger amounts of substrate to produce detectable levels of breakdown products in a given time. Enzymes which bring about chromogenic or fluorescent changes in their substrates are selected for enzyme immunoassays.</p>
                            <p>Enzyme immunoassay (EIA) includes all the techniques where enzymes are used to label antigen or antibody reactions. EIA can be carried out entirely in solution, when it is called homogeneous enzyme-linked assay. When some of the reactants are adsorbed on a solid phase it is called heterogeneous enzyme-linked or enzyme-linked immunosorbent assay (ELISA).</p>
                            <p>Homogeneous assays do not involve washing stage and are very rapid, but are not very sensitive. They can be used only for small molecules. Heterogeneous enzyme assay or ELISA, on the other hand, are comparatively slow, requiring several incubation and washing stages, but are very sensitive and suitable for large molecules. Antibodies are conjugated or labelled with an enzyme by the addition of glutaraldehyde in such a way that the resulting conjugates retain both immunological and enzyme activity. They can be assayed by their ability to breakdown a suitable substrate. The most commonly used enzymes are alkaline phosphatase and horseradish peroxidase, with their respective substrates of p-nitrophenyl phosphate and o-phenylene diamine dihydrochloride. The colour change in the substrate due to the enzyme activity is assessed visually or in a simple spectrophotometer.</p>
                            <p>ELISA techniques can be used to detect either antigen or antibody qualitatively or quantitatively. The two main techniques of ELISA are (i) Indirect ELISA to detect antibody and (ii) Sandwich ELISA or Double antibody ELISA to detect antigen.</p>

                            <h4>(i) Indirect ELISA</h4>
                            <p>A known antigen is attached to a solid phase such as the wall of the test tube, a micro-titre plate well or a bead. It is reacted with the test sample which may contain antibody. The test is incubated and followed by a wash. Subsequently, an enzyme-labelled anti-human globulin is reacted with the antibody in the test sample that has attached to the antigen on the solid phase.</p>
                            <p>After incubation, the uncombined labelled anti-human globulin is washed off.</p>
                            <p>Retention of enzyme on the surface is detected by addition of appropriate substrate which changes colour after incubation. (Fig. 4.21).</p>
                            <p>The concentration of antibody in the test sample bound by the antigen on the solid phase is proportional to the intensity of colour. The reaction is stopped by changing the pH with acid.</p>

                            <h4>(II) Sandwich antibody or double antibody ELISA</h4>
                            <p>This technique is used for the detection of antigen in the test sample. A known antibody is adsorbed on a solid phase, to which the test sample, which may contain the antigen, is added.</p>
                            <p>During incubation, the antibody captures or binds the antigen to the solid phase. After washing, enzyme labelled specific antibody is added. At this stage, the antigen is sandwiched between two antibody molecules, one on the solid phase and the other with the enzyme label.</p>
                            <p>On addition of substrate, a colour change indicates that the enzyme labelled antibody is present on the solid surface. This is due to the presence of antigen in the test sample (Fig. 4.21).</p>
                            <p>The enzyme activity is stopped after a fixed period by changing the pH with acid.</p>
                            <p>ELISA is now widely employed for the diagnosis of bacterial, viral and parasitic infections. Commercial kits are available for a wide range of diseases, for both antigen and antibody detection.</p>
                            <figure class="content-figure" data-lightbox="true">
                                <div class="figure-image-wrapper">
                                    <img src="../assets/images/img-54.jpeg" alt="Enzyme linked immunosorbent assay ((ELISA): (A) Direct, (B) Indirect and (C) Sandwich techniques." class="figure-image">
                                </div>
                                <figcaption class="figure-caption">Fig. 4.21 Enzyme linked immunosorbent assay ((ELISA): (A) Direct, (B) Indirect and (C) Sandwich techniques.</figcaption>
                            </figure>

                            <h3>Western Blot (Immunoblot)</h3>
                            <p>Western blot is a very innovative, sensitive and specific technique for antibody detection, which uses an enzyme label at the final stage. It is a very useful tool to distinguish a specific antibody response to different molecular weight protein antigens from a single infectious agent. Western blot (WB) is the most commonly employed as confirmatory test for the human immunodeficiency virus (HIV) infection for detecting antibodies for individual HIV antigens. Steps in the performance of WB assay.</p>
                            <p>There are seven basic steps involved in the performance of WB.</p>
                            <p>(i) The antigen sample is prepared by ultracentrifugation of cell-free supernatant from an HIV-producing cell-line.<br>
                            (ii) The proteins are separated by electrophoresis on a polyacrylamide gel.<br>
                            (iii) These resolved proteins are transferred onto nitrocellulose paper by placing the polyacrylamide gel together with a nitrocellulose sheet between several sheets of absorbant paper and then soaked in buffer for 2-3 days.<br>
                            (iv) The non-specific binding sites on the nitrocellulose paper are 'blocked' by placing them in a solution of dry milk (5%, w/v) or albumin, at 37¬∞C for 1 hour. This nitrocellulose sheet can be cut into strips, so that each strip can be used for a separate test sample.</p>
                            <p>(v) Patient's serum is then added for immunoreaction with separated, bound proteins on nitrocellulose. Antibodies in patient's serum bind to their corresponding antigens.<br>
                            (vi) Antigen-antibody binding is detected by addition of anti-human globulin labelled with either horseradish peroxidase or alkaline phosphatase.<br>
                            (vii) When appropriate substrates are added, these enzymes produce coloured bands at the electrophoretic position of the corresponding HIV antigens.</p>
                            <p>Figure 4.22 illustrates the steps involved in WB. Interpretation of WB results for HIV. There are three major structural genes in HIV, and three major products of each gene which are generally visualized in a WB. These are:</p>
                            <p>Envelope glycoproteins - gp 160, gp 120, gp 41<br>
                            Polymerase proteins - p65, p53, p34<br>
                            Group-specific antigen - p55, p24, p17.<br>
                            (gag)</p>
                            <p>There are different criteria for interpretation of HIV WB test results. Generally, reactivity to at least one antigen from each group is considered positive.</p>
                            <div class="callout callout--note">
                                <div class="callout-header">
                                    <span class="callout-icon">‚ÑπÔ∏è</span>
                                    <h4 class="callout-title">Note</h4>
                                </div>
                                <div class="callout-content">
                                    <p>Southern blot is a similar technique used for nucleic acids instead of proteins.</p>
                                </div>
                            </div>
                            <figure class="content-figure" data-lightbox="true">
                                <div class="figure-image-wrapper">
                                    <img src="../assets/images/img-62.jpeg" alt="Western Blot Technique" class="figure-image">
                                </div>
                                <figcaption class="figure-caption">Fig. 4.22 Western Blot Technique (Diagram inferred from text)</figcaption>
                            </figure>
                        </div>
                    </section>

                    <!-- Section 10: Miscellaneous Tests -->
                    <section class="content-section" id="miscellaneous">
                        <div class="section-header">
                            <div class="section-number">10</div>
                            <h2 class="section-title">
                                <span class="title-icon">üìö</span>
                                Miscellaneous Tests
                            </h2>
                        </div>

                        <div class="content-card">
                            <p>Other applications of antigen-antibody reaction in diagnosis include:</p>

                            <h3>A. Complement Dependent Tests</h3>
                            <p>(i) Immobilisation test When motile bacteria are mixed with specific antiserum in presence of complement, they are rendered nonmotile (immobilised). This test is useful for the identification of bacteria such as <em>Vibrio cholerae</em> in stool specimen or for the detection of antibody to <em>Treponema pallidum</em> in patient's serum.</p>
                            <p>(ii) Immune adherence test When some bacteria react with their antibody in the presence of complement and some other cells such as red cells or platelets, they form aggregates which are seen to adhere to these cells.</p>

                            <h3>B. Immune-electron Microscopy</h3>
                            <p>The clumping of virus particles by specific antibody can be visualized in the electron microscope directly e.g. rotavirus in stool, hepatitis-B virus in serum or adenovirus in respiratory secretions.</p>
                            <p>The clumping of virus particles by antibody can be more easily detected by electron microscopy when the antibody is conjugated with ferritin, which is an electron-dense substance from horse spleen.</p>

                            <h3>C. Capsule-swelling or Quellung Reaction</h3>
                            <p>When capsulated bacteria such as <em>Streptococcus pneumoniae</em> are mixed with their respective type-specific antisera, swelling of the capsule occurs. This is one of the methods of serotyping based on the capsular antigens and is known as Quellung reaction. The results can be observed under the microscope.</p>
                        </div>
                    </section>

                </main>

                <!-- BOTTOM NAVIGATION -->
                <nav class="document-nav" role="navigation" aria-label="Document Navigation">
                    <div class="nav-links">
                        <a href="topic-03-specific-immune-response.html" class="nav-button nav-button--previous">
                            <span class="nav-icon">‚Üê</span>
                            <span class="nav-text">Previous</span>
                        </a>
                        
                        <a href="../index.html" class="nav-button">
                            <span class="nav-icon">üè†</span>
                            <span class="nav-text">Home</span>
                        </a>
                        
                        <a href="topic-05-serodiagnostic-tests.html" class="nav-button nav-button--next">
                            <span class="nav-text">Next</span>
                            <span class="nav-icon">‚Üí</span>
                        </a>
                    </div>
                    <div class="document-progress">
                        <div class="progress-bar" aria-hidden="true">
                            <div class="progress-fill" style="width: 80%;"></div>
                        </div>
                        <span class="progress-text">Topic 4 of 5</span>
                    </div>
                </nav>

            </article>
        </div>
    </div>

    <!-- Lightbox Modal -->
    <div id="lightbox" class="lightbox-modal" hidden aria-hidden="true" role="dialog" aria-label="Image viewer">
        <div class="lightbox-backdrop"></div>
        <div class="lightbox-content">
            <button class="lightbox-close" aria-label="Close image viewer">√ó</button>
            <img class="lightbox-image" src="" alt="">
            <p class="lightbox-caption"></p>
        </div>
    </div>

    <!-- Scripts -->
    <script src="../js/theme.js"></script>
    <script src="../js/navigation.js"></script>
    <script src="../js/interactions.js"></script>
</body>
</html>